Skip to content
OpenCapital
Get started

Olema Pharmaceuticals, Inc. OLMA Balance Sheet Statement

Income StatementBalance SheetCash FlowRatiosSegments
QuarterlyAnnualTTM
YoYQoQ
SimplifiedDetailed
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Cash and cash equivalents
$52.55M+8.8%$48.3M+37.0%$35.26M-32.8%$52.47M+3.6%$50.64M-63.7%
Short-term investments
$452.8M-0.9%$457.14M+55.6%$293.7M-5.1%$309.44M-9.5%$342.07M+16.1%
Total current assets
$513.23M-0.4%$515.45M+54.2%$334.33M-9.1%$367.73M-7.3%$396.66M-9.5%
Total assets
$530.65M-0.5%$533.43M+51.3%$352.45M-7.7%$382M-6.7%$409.64M-9.2%
Accounts payable
$3.72M-59.8%$9.25M+166%$3.47M+272%$934K+519%$151K-96.6%
Total current liabilities
$47.17M-8.9%$51.8M+24.4%$41.66M+25.6%$33.16M+27.2%$26.06M-37.6%
Total liabilities
$50.17M-8.6%$54.87M+22.0%$44.97M+22.3%$36.77M+40.4%$26.19M-37.7%
Common stock
$8K0.0%$8K+14.3%$7K0.0%$7K0.0%$7K0.0%
Retained earnings
-$650.65M-8.9%-$597.56M-8.4%-$551.5M-8.3%-$509.28M-9.4%-$465.5M-7.0%
Total stockholders' equity
$480.48M+0.4%$478.56M+55.6%$307.49M-10.9%$345.24M-10.0%$383.45M-6.2%
Total liabilities and stockholders' equity
$530.65M-0.5%$533.43M+51.3%$352.45M-7.7%$382M-6.7%$409.64M-9.2%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Olema Pharmaceuticals, Inc.'s total assets?
Olema Pharmaceuticals, Inc. (OLMA) holds $530.6M in total assets, up 29.5% year over year.
How much debt does Olema Pharmaceuticals, Inc. have?
Olema Pharmaceuticals, Inc. carries $956.0K in total debt against $480.5M of shareholders' equity, a debt-to-equity ratio of 0.00.
How much cash does Olema Pharmaceuticals, Inc. have?
Olema Pharmaceuticals, Inc. holds $52.5M in cash and equivalents.
Can Olema Pharmaceuticals, Inc. cover its short-term obligations?
Its current ratio is 10.88 — current assets exceed current liabilities.
Where does Olema Pharmaceuticals, Inc.'s balance sheet data come from?
Every line is extracted from Olema Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.